Whole-pelvis radiotherapy (WPRT) improves biochemical recurrence-free survival (bRFS), but not distant metastasis-free survival (DMFS) and prostate cancer-specific survival (PCSS), in patients with Gleason grade group 5 prostate cancer (PCa) treated with either external-beam radiotherapy (EBRT) or EBRT with a brachytherapy boost (EBRT+BT), a recent study has found.
The addition of the oral phosphodiesterase-5 (PDE-5) inhibitor pentoxifylline to sildenafil failed to show benefit in men with erectile dysfunction (ED) with suboptimal response to sildenafil, a Singapore study shows.
A novel low-intensity pulsed ultrasound (LIPUS) holds therapeutic potential in patients with mild-to-moderate erectile dysfunction (ED), restoring erectile function without deleterious consequences—a benefit attributed to the mechanical force of the device that can reverse the pathological changes in the corpus cavernosum, as shown in a recent study.
The last decade has seen a significant increase in the use of neoadjuvant chemotherapy for nonmetastatic muscle invasive urothelial bladder cancer, and a recent study has shown that its utilization is not associated with adverse perioperative outcome following robot-assisted radical cystectomy.
Dr Dariusz P. Olszyna, a senior consultant at the Division of Infectious Diseases, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the importance of early detection to prevent the spread and complications related to sexually-transmitted infections (STIs).
Eight new endoscopic surgical methods for benign prostatic hyperplasia appear to be better than monopolar transurethral resection of the prostate (TURP) in terms of safety, according to a study. Among these treatments, enucleation methods achieve better maximal flow rate (Qmax) and international prostate symptoms score (IPSS) than vaporization and resection methods.
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).